{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:38Z","timestamp":1785542438434,"version":"3.56.0"},"reference-count":39,"publisher":"Baskent University","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.6002\/ect.2018.0371","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T09:24:16Z","timestamp":1562232256000},"page":"324-332","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Outcomes of Patients With Amyloidosis Following Kidney Transplant"],"prefix":"10.6002","volume":"21","author":[{"given":"Cihan","family":"Heybeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Asi","family":"Oktan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekai Serhan","family":"Derici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtat","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Cavdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aykut","family":"Sifil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulen","family":"Sarioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Camsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"issue":"12","key":"ref0","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","unstructured":"1. Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458-3471.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3324\/haematol.2013.087619","article-title":"Update on treatment of light chain amyloidosis","volume":"99","author":"Mahmood","year":"2014","unstructured":"2. Mahmood S, Palladini G, Sanchorawala V, Wechalekar A. Update on treatment of light chain amyloidosis. Haematologica. 2014;99(2):209-221.","journal-title":"Haematologica"},{"issue":"10","key":"ref2","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1016\/j.transproceed.2013.09.021","article-title":"Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience","volume":"45","author":"Abedi","year":"2013","unstructured":"3. Abedi AS, Nakhjavani JM, Etemadi J. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc. 2013;45(10):3502-3504.","journal-title":"Transplant Proc"},{"issue":"7","key":"ref3","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.transproceed.2005.07.010","article-title":"Effect of amyloidosis on long-term survival in kidney transplantation","volume":"37","author":"Emiroglu","year":"2005","unstructured":"4. Emiroglu R, Basaran O, Pehlivan S, et al. Effect of amyloidosis on long-term survival in kidney transplantation. Transplant Proc. 2005;37(7):2967-2968.","journal-title":"Transplant Proc"},{"issue":"2","key":"ref4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.transproceed.2005.12.051","article-title":"Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis","volume":"38","author":"Ozdemir","year":"2006","unstructured":"5. Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M. Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis. Transplant Proc. 2006;38(2):432-434.","journal-title":"Transplant Proc"},{"issue":"7","key":"ref5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/ctr.12749","article-title":"Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever","volume":"30","author":"Altindal","year":"2016","unstructured":"6. Altindal M, Turkmen E, Yildirim T, et al. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever. Clin Transplant. 2016;30(7):787-790.","journal-title":"Clin Transplant"},{"key":"ref6","unstructured":"7. Tatar E, Karatas M, Aykas A, Okut G, Bozkaya G, Uslu A. Infections after renal transplant in recipients with familial Mediterranean fever: a life-threatening issue. Exp Clin Transplant. 2017;15(Suppl 1):240-243."},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis","volume":"42","author":"Sherif","year":"2003","unstructured":"8. Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis. 2003;42(2):370-375.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.transproceed.2016.04.015","article-title":"Comparative analysis of outcomes of kidney transplantation in patients with AA amyloidosis and chronic glomerulonephritis","volume":"48","author":"Sahutoglu","year":"2016","unstructured":"9. Sahutoglu T, Atay K, Caliskan Y, Kara E, Yazici H, Turkmen A. Comparative analysis of outcomes of kidney transplantation in patients with AA amyloidosis and chronic glomerulonephritis. Transplant Proc. 2016;48(6):2011-2016.","journal-title":"Transplant Proc"},{"issue":"10","key":"ref9","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1097\/TP.0000000000001681","article-title":"Familial Mediterranean fever is associated with increased mortality after kidney transplantation-a 19 years' single center experience","volume":"101","author":"Green","year":"2017","unstructured":"10. Green H, Lichtenberg S, Rahamimov R, et al. Familial Mediterranean fever is associated with increased mortality after kidney transplantation-a 19 years' single center experience. Transplantation. 2017;101(10):2621-2626.","journal-title":"Transplantation"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.transproceed.2006.01.003","article-title":"Outcome of kidney transplantation for renal amyloidosis: a single-center experience","volume":"38","author":"Celik","year":"2006","unstructured":"11. Celik A, Saglam F, Dolek D, et al. Outcome of kidney transplantation for renal amyloidosis: a single-center experience. Transplant Proc. 2006;38(2):435-439.","journal-title":"Transplant Proc"},{"issue":"11","key":"ref11","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","unstructured":"12. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11(11):2279-2296.","journal-title":"Am J Transplant"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"30","author":"Sawinski","year":"2015","unstructured":"13. Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209-217.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"ref13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/j.ajkd.2006.03.036","article-title":"Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy","volume":"47","author":"Sucker","year":"2006","unstructured":"14. Sucker C, Hetzel GR, Grabensee B, Stockschlaeder M, Scharf RE. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis. 2006;47(6):947-955.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<68::AID-AJH10>3.0.CO;2-6","article-title":"Normalization of plasma factor X levels in amyloidosis after plasma exchange","volume":"54","author":"Beardell","year":"1997","unstructured":"15. Beardell FV, Varma M, Martinez J. Normalization of plasma factor X levels in amyloidosis after plasma exchange. Am J Hematol. 1997;54(1):68-71.","journal-title":"Am J Hematol"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00001721-200209000-00011","article-title":"Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis","volume":"13","author":"Emori","year":"2002","unstructured":"16. Emori Y, Sakugawa M, Niiya K, et al. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis. Blood Coagul Fibrinolysis. 2002;13(6):555-559.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.4081\/hr.2018.7235","article-title":"Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver","volume":"10","author":"Nguyen","year":"2018","unstructured":"17. Nguyen AL, Kamal M, Raghavan R, Nagaraj G. Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver. Hematol Rep. 2018;10(3):7235.","journal-title":"Hematol Rep"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archinte.1983.00350030211041","article-title":"Resolution of factor X deficiency in primary amyloidosis following splenectomy","volume":"143","author":"Rosenstein","year":"1983","unstructured":"18. Rosenstein ED, Itzkowitz SH, Penziner AS, Cohen JI, Mornaghi RA. Resolution of factor X deficiency in primary amyloidosis following splenectomy. Arch Intern Med. 1983;143(3):597-599.","journal-title":"Arch Intern Med"},{"issue":"19","key":"ref18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJM197911083011907","article-title":"Factor X deficiency in primary amyloidosis: resolution after splenectomy","volume":"301","author":"Greipp","year":"1979","unstructured":"19. Greipp PR, Kyle RA, Bowie EJ. Factor X deficiency in primary amyloidosis: resolution after splenectomy. N Engl J Med. 1979;301(19):1050-1051.","journal-title":"N Engl J Med"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.gassur.2003.10.014","article-title":"Successful perioperative management of factor X deficiency associated with primary amyloidosis","volume":"8","author":"Takabe","year":"2004","unstructured":"20. Takabe K, Holman PR, Herbst KD, Glass CA, Bouvet M. Successful perioperative management of factor X deficiency associated with primary amyloidosis. J Gastrointest Surg. 2004;8(3):358-362.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1182\/blood.V97.6.1885","article-title":"Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy","volume":"97","author":"Choufani","year":"2001","unstructured":"21. Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001;97(6):1885-1887.","journal-title":"Blood"},{"issue":"2","key":"ref21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1023\/A:1007196926394","article-title":"Spontaneous regression of bilateral surrenal haematoma and subclinical hypoaldosteronism in a patient with renal amyloidosis secondary to Familial Mediterranean Fever","volume":"32","author":"Kara","year":"2000","unstructured":"22. Kara, Paydas S. Spontaneous regression of bilateral surrenal haematoma and subclinical hypoaldosteronism in a patient with renal amyloidosis secondary to Familial Mediterranean Fever. Int Urol Nephrol. 2000;32(2):291-292.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"ref22","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1128\/JVI.02627-06","article-title":"Human serum amyloid A protein inhibits hepatitis C virus entry into cells","volume":"81","author":"Cai","year":"2007","unstructured":"23. Cai Z, Cai L, Jiang J, Chang KS, van der Westhuyzen DR, Luo G. Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J Virol. 2007;81(11):6128-6133.","journal-title":"J Virol"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3233\/JAD-150652","article-title":"Protective effect of amyloid-beta peptides against herpes simplex virus-1 infection in a neuronal cell culture model","volume":"50","author":"Bourgade","year":"2016","unstructured":"24. Bourgade K, Le Page A, Bocti C, et al. Protective effect of amyloid-beta peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis. 2016;50(4):1227-1241.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/ajcn\/83.2.350","article-title":"Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1","volume":"83","author":"Caccialanza","year":"2006","unstructured":"25. Caccialanza R, Palladini G, Klersy C, et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1. Am J Clin Nutr. 2006;83(2):350-354.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"ref25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.amjmed.2007.02.023","article-title":"Orthostatic hypotension in the elderly: diagnosis and treatment","volume":"120","author":"Gupta","year":"2007","unstructured":"26. Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120(10):841-847.","journal-title":"Am J Med"},{"issue":"8","key":"ref26","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3324\/haematol.2008.004119","article-title":"Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain","volume":"94","author":"van Gameren","year":"2009","unstructured":"27. van Gameren II, van Rijswijk MH, Bijzet J, Vellenga E, Hazenberg BP. Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica. 2009;94(8):1094-1100.","journal-title":"Haematologica"},{"issue":"17","key":"ref27","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2169\/internalmedicine.53.2065","article-title":"Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation","volume":"53","author":"Katoh","year":"2014","unstructured":"28. Katoh N, Matsushima A, Kurozumi M, Matsuda M, Ikeda S. Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation. Intern Med. 2014;53(17):1991-1995.","journal-title":"Intern Med"},{"issue":"7","key":"ref28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.healun.2008.11.918","article-title":"Regression of cardiac amyloid after autologous stem-cell transplantation","volume":"28","author":"Blair","year":"2009","unstructured":"29. Blair JE, Zeigler SM, Mehta J, Singhal S, Cotts W. Regression of cardiac amyloid after autologous stem-cell transplantation. J Heart Lung Transplant. 2009;28(7):746-748.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"ref29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/lt.21395","article-title":"Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation","volume":"14","author":"Tsuchiya","year":"2008","unstructured":"30. Tsuchiya A, Yazaki M, Kametani F, Takei Y, Ikeda S. Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl. 2008;14(4):563-570.","journal-title":"Liver Transpl"},{"issue":"3","key":"ref30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/13506129.2013.807790","article-title":"Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy","volume":"20","author":"Tsuchiya-Suzuki","year":"2013","unstructured":"31. Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, Kametani F, Ikeda S. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy. Amyloid. 2013;20(3):156-163.","journal-title":"Amyloid"},{"issue":"8853","key":"ref31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","article-title":"Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis","volume":"341","author":"Holmgren","year":"1993","unstructured":"32. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341(8853):1113-1116.","journal-title":"Lancet"},{"issue":"10","key":"ref32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/MEG.0b013e32833dbd81","article-title":"Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation","volume":"22","author":"Van Steenbergen","year":"2010","unstructured":"33. Van Steenbergen W, Braeye L, Harlet R, et al. Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol. 2010;22(10):1265-1270.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"ref33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s002590050273","article-title":"Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation","volume":"25","author":"Rydh","year":"1998","unstructured":"34. Rydh A, Suhr O, Hietala SO, Ahlstrom KR, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med. 1998;25(7):709-713.","journal-title":"Eur J Nucl Med"},{"issue":"12","key":"ref34","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/ndt\/gfg436","article-title":"No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement","volume":"18","author":"Zeier","year":"2003","unstructured":"35. Zeier M, Perz J, Linke RP, et al. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement. Nephrol Dial Transplant. 2003;18(12):2644-2647.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"ref35","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.transproceed.2004.09.065","article-title":"Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience","volume":"36","author":"Keven","year":"2004","unstructured":"36. Keven K, Sengul S, Kutlay S, et al. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc. 2004;36(9):2632-2634.","journal-title":"Transplant Proc"},{"issue":"8","key":"ref36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10067-012-1992-6","article-title":"Renal transplantation in patients with familial Mediterranean fever","volume":"31","author":"Erdem","year":"2012","unstructured":"37. Erdem E, Karatas A, Kaya C, et al. Renal transplantation in patients with familial Mediterranean fever. Clin Rheumatol. 2012;31(8):1183-1186.","journal-title":"Clin Rheumatol"},{"key":"ref37","unstructured":"38. Turkmen A, Yildiz A, Erkoc R, et al. Transplantation in renal amyloidosis. Clin Transplant. 1998;12(5):375-378."},{"issue":"11","key":"ref38","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/j.1600-6143.2011.03620.x","article-title":"Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study","volume":"11","author":"Kofman","year":"2011","unstructured":"39. Kofman T, Grimbert P, Canoui-Poitrine F, et al. Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study. Am J Transplant. 2011;11(11):2423-2431.","journal-title":"Am J Transplant"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T02:34:41Z","timestamp":1683599681000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2023\/21\/4\/0\/324\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2018.0371","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}